Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,114 | 214 | 96.0% |
| Travel and Lodging | $212.63 | 1 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,596 | 18 | $0 (2020) |
| Amgen Inc. | $397.73 | 38 | $0 (2023) |
| PFIZER INC. | $391.64 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $389.25 | 35 | $0 (2024) |
| ShockWave Medical, Inc | $348.19 | 5 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $283.02 | 11 | $0 (2024) |
| Biosense Webster, Inc. | $272.71 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $249.35 | 17 | $0 (2023) |
| Medtronic, Inc. | $180.06 | 8 | $0 (2024) |
| Esperion Therapeutics, Inc. | $153.08 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $784.51 | 27 | Biosense Webster, Inc. ($272.71) |
| 2023 | $905.27 | 35 | ABIOMED ($152.94) |
| 2022 | $705.91 | 23 | Shockwave Medical, Inc ($238.35) |
| 2021 | $406.02 | 28 | Novartis Pharmaceuticals Corporation ($131.20) |
| 2020 | $373.71 | 33 | Amgen Inc. ($221.55) |
| 2019 | $286.22 | 13 | Medtronic Vascular, Inc. ($131.73) |
| 2018 | $1,232 | 28 | Medtronic Vascular, Inc. ($988.57) |
| 2017 | $633.03 | 28 | Medtronic Vascular, Inc. ($365.46) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Genetic Disease | ||||||
| 10/08/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 10/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.83 | General |
| 08/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology | ||||||
| 08/06/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 08/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Not Applicable | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Genetic Disease | ||||||
| 07/01/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/06/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Genetic Disease | ||||||
| 05/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/05/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $38.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Biosense Webster, Inc. | QDOT MICRO Catheter (Device) | Food and Beverage | In-kind items and services | $197.71 | General |
| 04/30/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Genetic Disease | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/22/2024 | Biosense Webster, Inc. | QDOT MICRO Catheter (Device) | Food and Beverage | In-kind items and services | $75.00 | General |
| 04/12/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,542 | 5,545 | $701,131 | $190,402 |
| 2022 | 26 | 2,704 | 5,896 | $674,794 | $190,894 |
| 2021 | 34 | 2,937 | 6,175 | $825,087 | $231,892 |
| 2020 | 31 | 2,867 | 6,608 | $844,667 | $243,667 |
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 363 | $50,190 | $30,705 | 61.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 128 | 929 | $70,604 | $22,365 | 31.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 112 | 833 | $42,483 | $15,034 | 35.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 334 | 857 | $54,848 | $11,556 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 88 | $17,320 | $10,746 | 62.0% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 25 | 25 | $75,625 | $10,106 | 13.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 207 | 522 | $36,540 | $10,039 | 27.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 68 | 77 | $79,541 | $9,863 | 12.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 139 | 184 | $22,632 | $9,807 | 43.3% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 12 | 12 | $42,900 | $8,354 | 19.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 133 | 339 | $43,053 | $8,066 | 18.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 22 | 22 | $40,392 | $6,592 | 16.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 60 | 81 | $17,010 | $5,791 | 34.0% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 45 | 56 | $10,640 | $3,708 | 34.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 56 | $5,264 | $3,443 | 65.4% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 95 | 105 | $6,405 | $3,350 | 52.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 25 | 25 | $10,000 | $2,471 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 43 | 43 | $6,450 | $2,212 | 34.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 198 | 238 | $15,708 | $2,186 | 13.9% |
| 92960 | External shock to heart to regulate heart beat | Office | 2023 | 14 | 18 | $9,000 | $2,095 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,287 | $1,924 | 58.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 272 | 292 | $11,388 | $1,827 | 16.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 20 | 101 | $5,757 | $1,760 | 30.6% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 28 | 31 | $4,433 | $1,504 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,123 | $1,182 | 55.7% |
About Dr. Henry Patrick, MD
Dr. Henry Patrick, MD is a Cardiovascular Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780685917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Patrick, MD has received a total of $5,327 in payments from pharmaceutical and medical device companies, with $784.51 received in 2024. These payments were reported across 215 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,114).
As a Medicare-enrolled provider, Patrick has provided services to 11,050 Medicare beneficiaries, totaling 24,224 services with total Medicare billing of $856,855. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Baton Rouge, LA
- Active Since 08/10/2005
- Last Updated 04/27/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780685917
Products in Payments
- Micra (Device) $713.49
- ELIQUIS (Drug) $373.85
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $348.19
- Reveal LINQ (Device) $346.98
- ENTRESTO (Drug) $320.92
- ONPATTRO (Drug) $283.02
- QDOT MICRO Catheter (Device) $272.71
- Corlanor (Drug) $270.07
- XARELTO (Drug) $249.35
- Claria MRI (Device) $176.82
- CoreValve Evolut (Device) $160.91
- NEXLETOL (Drug) $153.08
- Impella (Device) $152.94
- AMPLATZER (Device) $145.80
- Azure (Device) $138.33
- CHANTIX (Drug) $128.66
- Repatha (Biological) $127.66
- ZIO XT Patch (Device) $94.49
- TYRX (Device) $78.21
- LEQVIO (Drug) $68.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Baton Rouge
Denzil Moraes, M.d, M.D
Cardiovascular Disease — Payments: $1.3M
George Karam, Md, MD
Cardiovascular Disease — Payments: $321,210
David Moll, Md, MD
Cardiovascular Disease — Payments: $128,748
Mark Pollet, Md, MD
Cardiovascular Disease — Payments: $116,274
Dr. Tara Jarreau, M.d, M.D
Cardiovascular Disease — Payments: $111,344
Venkata Satish Gadi, M.d, M.D
Cardiovascular Disease — Payments: $105,858